MAPT and Alzheimer disease: These results collectively suggest that the effect of SCFAs in mediating the association between GM dysbiosis and cognitive impairment might be mediated by amyloid and tau in CI-AD while it might act through more dynamic mediators (i.e., inflammation) in CI-NAD.